The Effect of Acute HMG-CoA-Reductase Inhibition (Atorvastatin) on Renal Sodium Excretion, Renal Hemodynamics, Tubular Function and Vasoactive Hormones in Healthy Subjects During Normal and High Sodium Intake.
Phase of Trial: Phase IV
Latest Information Update: 01 Jan 2009
At a glance
- Drugs Atorvastatin (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics; Pharmacokinetics
- 22 May 2008 New trial record.